The short version of LC-MS/MS fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-10-18 and is reviewed periodically as new material appears.
Retatrutide is an investigational synthetic peptide developed under the code LY3437943, with a backbone derived from glucose-dependent insulinotropic polypeptide. Several non-proteinogenic residues, including alpha-aminoisobutyric acid, appear in that backbone, and a fatty diacid side chain attached through a linker extends circulation time. The molecule carries roughly thirty-nine amino acid units and a total mass near 4.7 kilodaltons. Administration is by subcutaneous injection once weekly. Published work uses both the name retatrutide and the code LY3437943.
Pharmacologically the compound activates three receptors: GLP-1, GIP, and glucagon. GLP-1 and GIP signaling contribute to glucose-dependent insulin release, delayed gastric emptying, and reduced appetite, while glucagon receptor activation is associated with increased energy expenditure and hepatic fat oxidation. The single-molecule design is intended to keep these activities in one peptide rather than combining separate agents. Relative activity at each receptor differs, and the balance between them is a central question in interpretation. The glucagon component is partly offset by incretin-mediated insulin secretion, an interaction that remains incompletely characterized.
Quantification of the peptide in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. This approach separates the analyte from matrix components and detects it by mass-to-charge transitions specific to the molecule. Immunoassays offer higher throughput but can cross-react with related peptides and metabolites, so mass spectrometric methods are preferred when structural confirmation is required. Method validation typically addresses accuracy, precision, selectivity, and stability under handling conditions.
Several questions remain unresolved. It is not yet known whether the compound reduces cardiovascular events or mortality, because outcome studies require long follow-up. The durability of weight reduction after treatment withdrawal is uncertain, and rebound has been observed with other incretin-based therapies. Long-term safety data covering several years are limited. Effects in adolescents, in pregnancy, and in people with significant kidney or liver impairment have not been characterized in published reports.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide of about 39 residues | Backbone derived from a GIP sequence |
| Molecular mass | Approximately 4.7 kDa | Peptide chain plus fatty diacid moiety |
| Receptor targets | GLP-1, GIP, glucagon | Unimolecular triple agonist |
| Typical storage temperature | 2 to 8 degrees Celsius | Protect from light; avoid repeated freeze-thaw |
| Common analytical method | LC-MS/MS | Used for plasma quantification and purity checks |
Development has progressed through early- and mid-stage human studies in adults with obesity and with type 2 diabetes. Published phase 2 data reported reductions in body weight and improvements in glycemic markers over the treatment period. No regulatory agency has approved the compound for any indication, and it remains available only within controlled research settings. Whether benefits observed in trials translate into durable outcomes after treatment stops is not yet established.
Retatrutide is an investigational synthetic peptide that acts as an agonist at three distinct G protein-coupled receptors. It combines activity at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor within a single molecule. This multi-receptor profile distinguishes it from earlier incretin-based compounds that engage one or two of these pathways. Researchers designed the molecule to test whether simultaneous activation produces greater metabolic effects than single or dual agonism alone.
The peptide backbone is chemically modified to resist rapid enzymatic breakdown in the body. A fatty acid side chain promotes binding to serum albumin, which slows renal clearance and supports an extended circulation time. These modifications allow less frequent administration than would be possible with an unmodified peptide. The precise contribution of glucagon receptor activation to the overall metabolic effect remains an area of active investigation, because glucagon raises glucose while also increasing energy expenditure.
Identity and purity are established by instrumental methods rather than by appearance. Reversed-phase high-performance liquid chromatography separates the peptide from related impurities and yields a purity value, usually expressed as the share of total peak area. Mass spectrometry checks that the observed mass agrees with the mass calculated from the published sequence, while peptide mapping or amino acid analysis adds structural evidence. Water content, counter-ion identity and residual solvents are sometimes reported as well. A certificate of analysis should name the method behind each figure, because results are method-dependent.
Laboratory handling follows the conventions used for other synthetic peptides. Lyophilized material is weighed and dissolved in an aqueous diluent, typically sterile water or bacteriostatic water, using gentle swirling rather than vigorous shaking, because foaming stresses the chain. Solutions are prepared under clean conditions and, where sterility matters, passed through a suitable filter. Working portions are kept small so that stock material is not repeatedly warmed and cooled, a practice that limits both aggregation and gradual loss of activity.
==== Opium ==== Liu reportedly called opium cultivation the "lifeline" of the 24th Army and derived much of his income from the drug, which was traded and later cultivated on a massive scale. The opium business became extremely profitable after 1936 when the central government started aggressively suppressing production within the Sichuan basin, making opium grown by the Yi in the Xikang highlands extremely profitable. Lawson went as far as to conclude that the Kuomintang's anti-opium campaign was arguably "another form of assistance that the national government granted Liu Wenhui". A similar period of suppression in the lowlands coinciding with an opium boom in the highlands was also documented from 1906 to 1911 under the Qing dynasty. Cultivation of opium in Kham began after 1936, spreading to Liu's territories around the early 1940s. Liu Wenhui profited greatly from this illegal trade, and was able to fund his military and economic projects through opium sales. In 1940, he was alleged to have struck a deal with the Yunnanese governor Long Yun that let tariffed opium from Yunnan pass through Xikang en route to Sichuan. Later, this trade would decline as Xikang became a major opium producer in its own right. Historians including Lawson have so far been unable to place an exact amount on the income that Xikang gained from opium; only that it was probably at least as much as the subsidy Xikang received from the central government.
Jung's thought derived from the classical education he received at school and from early family influences, which on the maternal side were a combination of Reformed Protestant academic theology with an interest in occult phenomena. On his father's side was a dedication to academic discipline emanating from his grandfather - the physician, scientist, one-time student activist and convert from Catholicism to Swiss Reformed Protestantism, and first Basel Professor of Medicine, Karl Gustav Jung. Family lore also suggested there was at least a social connection to the German polymath, Johann Wolfgang Goethe, through the latter's niece, Lotte Kestner (known as "Lottchen") who was a frequent visitor in Jung senior's household. Jung had, through his marriage, the economic security to pursue interests in other intellectual topics of the moment. His early celebrity as a research scientist through the Word Association Test led to the start of prolific correspondence and worldwide travel. It opened academic as well as social avenues, supported by his explorations into anthropology, quantum physics, vitalism, Eastern and Western philosophy. He delved into epistemology, alchemy, astrology, and sociology, as well as literature and the arts. Jung's interest in philosophy and spiritual subjects led many to label him a mystic, although he preferred to be seen as a man of science. Jung, unlike Freud, was deeply knowledgeable about philosophical concepts and sought links between epistemology and emergent theories of psychology.
Deman acknowledges that Wolverine is a gruff loner who often takes leave from the X-Men to deal with personal issues or problems, irreverent and rebellious towards authority figures, and displays a wry, sarcastic sense of humor. Despite this, Deman also notes that Wolverine is a reliable ally and competent leader, as well as capable of warmth, compassion, and empathy. Clinical psychologist and Navy veteran Larry Yarbrough recognizes that while "Logan has an extremely reactive temper" he is "also a kind person", pointing out that the "violent/kind demeanor" he displays is typical of combat veterans. According to him, Wolverine's "violent mood swings are a symptom of trauma, not a reflection of his character". He also observes Wolverine's habitual smoking and drinking, which are coping mechanisms for his traumatic experiences. Psychologist Suzana E. Flores writes that Wolverine demonstrates clinical psychological symptoms of post-traumatic stress disorder, bipolar disorder, antisocial personality disorder, dissociative disorder, and even sociopathy, but does so in a way that can be understood and empathized. She interprets his origin story as a depiction of complex childhood trauma, and its effects of dissociative amnesia and hypervigilance. She argues that his first formative trauma was his poor relationship with his mother, who was unable to properly attach to him because she lost her first son. In adulthood, he also suffered the trauma of torture by the Weapon X program.
=== Reception by Appalachians === Many Appalachians appreciated the memoir's recounting of Vance's childhood experiences but protested the book's generalizations of those experiences to Appalachian culture. Some Appalachian critics argued that Vance caricatured Appalachia and relied on existing stereotypes. They blamed the book's popularity for amplifying these stereotypes. Further complaints included that Vance blamed poverty on individuals and their decisions rather than documented systemic and historic issues. Vance's critiques of Appalachian culture included calling many people in the community lazy, and the books' subtitle, "A Memoir of a Family and Culture in Crisis", offended some Appalachian critics with its implied condemnation of Appalachian culture. Other complaints said the book flattened Appalachian culture and erased its diversity. At the 2018 Appalachian Studies Association conference, Young Appalachian Leaders and Learners (Y'ALL) protested Vance during a panel by turning their chairs from him and singing "Which Side are You On?".
Sources: en.wikipedia.org
Epidemiological studies have shown a clear association between breathing high concentrations of radon and incidence of lung cancer. Radon is a contaminant that affects indoor air quality worldwide. Because radon is denser than air it accumulates in basements and crawlspaces under dwellings. According to the United States Environmental Protection Agency (EPA), radon is the second most frequent cause of lung cancer, after cigarette smoking, causing 21,000 lung cancer deaths per year in the United States. About 2,900 of these deaths occur among people who have never smoked. While radon is the second most frequent cause of lung cancer, it is the number one cause among non-smokers, according to EPA policy-oriented estimates. Significant uncertainties exist for the health effects of low-dose exposures. Due to local differences in geology, the level of exposure to radon gas differs by location.
30 July – The Parliamentary Commissioner for Standards launches an investigation into Nigel Farage over a potential breach of parliamentary rules over financial interests. Former Downing Street Chief of Staff Sue Gray is appointed to the board of governors of Queen's University Belfast. Adam Holloway, the former Conservative MP for Gravesham, defects to Reform UK. 31 July – James Orr, chairman of the pro-Reform UK think tank, the Centre for a Better Britain, tells the Today programme an incoming Reform government would have to do some "very unpopular" things in its first 100 days in office and force "nasty cough medicine down the country's throat" but that if "Reform ends up governing the country, we should all want them to succeed".
state of Oklahoma to settle allegations that it had been overprescribing opioids, marketing them as safe, and downplaying their addictive qualities. In July 2019, Teva paid $69 million to settle pay-for-delay claims. In January 2020, Teva Pharmaceuticals agreed to pay $54 million to settle allegations under the False Claims Act that it violated the Anti-Kickback Statute by funding improper speaking programs to boost prescriptions. In 2021, New York Attorney General Letitia James filed a lawsuit against Teva and several other opioid manufacturers for their alleged contribution to the opioid epidemic in New York. In February 2022, Teva agreed to a $225 million settlement with the state of Texas to end claims that it fueled an opioid epidemic in the state by improperly marketing pain medicine. In August 2023, Teva admitted to price-fixing charges related to the generic cholesterol drug Pravastatin, and agreed to pay a $225 million fine, after a criminal investigation by the US Department of Justice. The US Department of Justice stated that the settlement was "the largest to date for a domestic antitrust cartel." Also in August 2023, Teva agreed to a legal settlement with US hospitals over its marketing of opioid products that ultimately raised costs for health providers and contributed to the opioid epidemic in the United States. The lawsuit consisted of roughly 500 hospitals and health providers, resulting in a payment from Teva of $126 million over 18 years.
The industrial-scale production of riboflavin uses various microorganisms, including filamentous fungi such as Ashbya gossypii, Candida famata and Candida flaveri, as well as the bacteria Corynebacterium ammoniagenes and Bacillus subtilis. B. subtilis that has been genetically modified to both increase the production of riboflavin and to introduce an antibiotic (ampicillin) resistance marker, is employed at a commercial scale to produce riboflavin for feed and food fortification. By 2012, over 4,000 tonnes per annum were produced by such fermentation processes. In the presence of high concentrations of hydrocarbons or aromatic compounds, some bacteria overproduce riboflavin, possibly as a protective mechanism. One such organism is Micrococcus luteus (American Type Culture Collection strain number ATCC 49442), which develops a yellow color due to production of riboflavin while growing on pyridine, but not when grown on other substrates, such as succinic acid.
== International reactions == Canada: Canada's ambassador to the United Nations compared U.S. president Donald Trump's Golden Dome to a protection racket after Trump said America's northern neighbor must either pay $61 billion to join the program or could agree to annexation (in which case inclusion would be free). Ambassador Bob Rae also noted that "threats to sovereign integrity are prohibited" under the Charter of the United Nations. Earlier, Canadian minister of national defence Bill Blair had expressed a willingness for participation in the Golden Dome project. China: On 21 May 2025, Foreign Ministry spokesperson Mao Ning criticized the Golden Dome plan, claiming it "violates the principle of peaceful use of space in the Outer Space Treaty". She called on the US to "give up developing and deploying [a] global anti-missile system", which risked "turning space into a war zone". In a white paper published by the State Council Information Office in November 2025, China criticized the move towards "absolute security" and that it would "pose a serious threat to outer space security". New Zealand: New Zealand defence minister Judith Collins expressed support for the Golden Dome missile system, saying "I don't see it as an attack mechanism. It's a defence mechanism. And if people did not feel they needed to defend themselves, they wouldn't waste the money on it." Trump had earlier noted the space-based system would be "a very big part of our defense and, obviously, of our offense" and capable of striking foreign assets even before they launch.
Sources: en.wikipedia.org
Jackson-Pratt drain – consists of a perforated round or flat tube connected to a negative pressure collection device. The collection device is typically a bulb with a drainage port which can be opened to remove fluid or air. After compressing the bulb to remove fluid or air, negative pressure is created as the bulb returns to its normal shape. Blake drain – a round silicone tube with channels that carry fluid to a negative pressure collection device. Drainage is thought to be achieved by capillary action, allowing fluid to travel through the open grooves into a closed cross section, which contains the fluid and allows it to be suctioned through the tube. Penrose drain – a soft rubber tube. Negative pressure wound therapy – Involves the use of enclosed foam and a suction device attached; this is one of the newer types of wound healing/drain devices which promotes faster tissue granulation, often used for large surgical/trauma/non-healing wounds. Redivac drain – a high negative pressure drain. Suction is applied through the drain to generate a vacuum and draw fluids into a bottle. Shirley drain. Chest tube – is a flexible plastic tube that is inserted through the chest wall and into the pleural space or mediastinum.
=== Television commercials === Wendy's Hamburger Chain ran a television commercial showing a supposed "Soviet Fashion Show", which featured the same large, unattractive woman wearing the same dowdy outfit in a variety of situations, the only difference being the accessory she carried (for example, a flashlight for 'nightwear' or a beach ball for 'swimwear'). This was supposedly a lampoon on how the Soviet society is characterised with uniformity and standardisation, in contrast to the US characterised with freedom of choice, as highlighted in the Wendy's commercial. Apple Computer's "1984" ad, despite paying homage to George Orwell's novel of the same name, follows a more serious yet ambitious take on the freedom vs. totalitarianism theme evident between the US and Soviet societies at the time.
==== Learning Resources, Inc. v. Trump ==== On August 29, 2025, the US Court of Appeals for the Federal Circuit ruled 7-4 that many of the Trump tariffs were invalid. The Appeals Court had ruled that the International Emergency Economic Powers Act (1977), did not grant the broad powers which the Trump administration was claiming. This decision did not affect some specific tariffs, such as steel or aluminum which were increased under other presidential authority. On February 20, 2026, the Supreme Court decided in Learning Resources, Inc. v. Trump that the IEEPA did not authorise the president to impose tariffs. All tariffs imposed under IEEPA were struck down.
=== Operation in Russia === Following Russia's invasion of Ukraine in 2022, GlaxoSmithKline (GSK) was criticized for continuing its operations in Russia, despite the ongoing conflict and international sanctions. Although GSK suspended clinical trials, advertising, and promotion in Russia, the company has maintained its supply of essential medicines, vaccines, and medical equipment, with proceeds reportedly directed towards humanitarian aid. Critics argue that GSK's decision to continue exporting products—resulting in increased sales and profit volumes in 2022 compared to 2021—undermines the intended impact of sanctions, raising ethical concerns.
== Clinical uses of C-peptide testing == Patients with diabetes may have their C-peptide levels measured as a means of distinguishing type 1 diabetes from type 2 diabetes or maturity-onset diabetes of the young (MODY). Measuring C-peptide can help to determine how much of their own natural insulin a person is producing as C-peptide is secreted in equimolar amounts to insulin. C-peptide levels are measured instead of insulin levels because C-peptide can assess a person's own insulin secretion even if they receive insulin injections, and because the liver metabolizes a large and variable amount of insulin secreted into the portal vein but does not metabolise C-peptide, meaning blood C-peptide may be a better measure of portal insulin secretion than insulin itself. A very low C-peptide confirms Type 1 diabetes and insulin dependence and is associated with high glucose variability, hyperglycaemia and increased complications. The test may be less sufficient to diagnose or recognize a subgroup of type 1 diabetes named Latent autoimmune diabetes in adults (LADA), whose C-peptide levels may not be as low as those in typical Type 1 diabetes while may sometimes overlap with those seen in type 2 diabetes, and Beta-cell antibody testing is needed for better diagnosis in this case. C-peptide can be used for differential diagnosis of hypoglycemia. The test may be used to help determine the cause of hypoglycaemia (low glucose), values will be low if a person has taken an overdose of insulin but not suppressed if hypoglycaemia is due to an insulinoma or sulphonylureas.
Sources: en.wikipedia.org
As of the mid-2020s retatrutide remains investigational and is not an approved medicine in the United States or the European Union. It has been supplied mainly to participants in clinical trials. Labels and availability can change, so regulatory listings should be checked directly.
Dual agonists act at the GLP-1 and GIP receptors, whereas retatrutide adds glucagon receptor activity on the same peptide. This third activity is the main structural and pharmacological distinction discussed in the literature. Direct head-to-head comparisons remain limited.
Reports usually give the study code LY3437943 alongside the name, the dose in milligrams, and the week at which an endpoint was measured. Percent body-weight change is the most frequent headline measure. Units and populations vary, so comparisons across reports require care.
Trials measure percentage change in body weight, absolute weight loss, and glycemic markers such as hemoglobin A1c. They also record blood pressure, lipids, and liver fat. Adverse events are tracked throughout.